Introduction
============

*Haemophilus parasuis* is a member of the family *Pasteurellaceae*, and is the causative agent of Glässer's disease in swine. *H. parasuis* could be a commensal organism of the upper respiratory tract of healthy pigs or pathogens causing systemic infection ([@ref-3]). Extensive heterogeneity among *H. parasuis* strains have been observed, and increasing efforts are made in deciphering the population structure and its possible relevance with clinical outcome ([@ref-22]; [@ref-11]; [@ref-31]; [@ref-39]).

Strain classification of *H. parasuis* has been widely studied serotypically, and genotypically, since differentiation of non-virulent strains from virulent strains is essential for diagnosis and control of the disease ([@ref-15]; [@ref-29]; [@ref-24]; [@ref-20]).

Serotyping is the most commonly used subtyping method, and is traditionally considered to be associated with virulence, but increasing evidence indicated that serovar is a poor proxy for virulence ([@ref-2]; [@ref-5]; [@ref-16]). Sequencing studies of *hsp60* and *16s rRNA* gene revealed two clades of strains in *H. parasuis* and the presence of a separate lineage of virulent strains ([@ref-24]; [@ref-1]). Population structure analysis at genome level revealed the separation of *H. parasuis* into two clades, which were further divided into five Bayesian analysis of population structure sub-clade, but no influence of disease association on population structure was observed ([@ref-11]). Hence, strains in certain sub-type tend to be virulent, but the relationship between sub-type and virulence phenotype is still not clear.

An increasing number of potential virulence markers (PVMs) have been identified for *H. parasuis*, of which some were already used for development of molecular methods for virulence prediction ([@ref-27]; [@ref-40]; [@ref-34]; [@ref-36]; [@ref-8]; [@ref-13]). As clinical data on these PVMs are still limited, its clinical relevance needs to be further confirmed.

Iron--sulfur clusters are essential protein cofactors that participate in numerous biological processes in most organisms ([@ref-28]). Iron--sulphur cluster regulator (*iscR*), a member of the Rrf2 family transcriptional regulators, is a global transcription regulator involving in various physiological processes during bacteria growth and stress responses. Growing evidence shows that *iscR* governs the proper regulation of virulence factors in many bacterial pathogens such as type III secretion system of *Yersinia pseudotuberculosis*, capsular polysaccharide biosynthesis of *Klebsiella pneumonia*, antigen I fimbriae of enterotoxigenic *Escherichia coli* and catalase A activity of *Pseudomonas aeruginosa* ([@ref-9]; [@ref-19]; [@ref-28]). *IscR* deficient mutant displays dramatic attenuation of virulence in several pathogens, and the important role of *iscR* in bacterial pathogenesis is becoming increasingly apparent ([@ref-7]; [@ref-19]).

The *iscR* gene was found in reference strains of all 15 serovars, but little is known about the role of *iscR* in pathogenicity of *H. parasuis* ([@ref-37]; [@ref-12]). *IscR* is a highly conserved protein among Proteobacteria and particularly within a certain species, but apparent amino acid substitutions were observed among 15 reference strains of *H. parasuis* ([@ref-12]; [@ref-18]; [@ref-28]). As *iscR* is a global regulator of virulence factors in many pathogenic bacteria, it is essential to evaluate the possible impact of the amino acid substitutions in *iscR* protein on population structure and clinical virulence of *H. parasuis*. In this study, population structure of *H. parasuis* was analyzed based on the phylogeny, serovars and PVMs profiles of 148 isolates. Meanwhile, potential correlation among population structure and clinical phenotype was explored.

Materials and Methods
=====================

Isolates and culture conditions
-------------------------------

A total of 148 *H. parasuis* strains were used in this study, of which 145 strains were isolated from clinical samples sent to our diagnostic center from September 2009 to January 2017, and the other three strains were isolated from nasal cavity ([Dataset S1](#supp-2){ref-type="supplementary-material"}). The isolates were originated from 125 independent pig farms in three provinces of eastern China. A sterile loop was used to inoculate TSA plates (supplemented with 2.5% bovine serum and 0.05% NAD) from samples of nasal cavity, lung, spleen, joint, brain, pericardium liquid, pleural effusion, and seroperitoneum. The plates were kept in a 37 °C incubator under humidified 5% CO~2~ for 24--72 h until the colony appears. Unequal number of colonies (from four to seven) was picked based on the number of samples, isolation sites or morphology of the colony for each independent farm, and each selected colony was inoculated on another TSA plate for further purification. Then, the isolates were transferred from TSA plates to TSB broth (supplemented with 2.5% bovine serum and 0.05% NAD) for bacteria enrichment.

Serovar determination
---------------------

Genome DNA of *H. parasuis* was extracted by digestion with proteinase K, and the isolates were identified by a species specific PCR test ([@ref-1]). Serovars of the isolates were determined by the two newly developed molecular serotyping methods, which were faster, more sensitive, and more specific than the traditional IHA ([@ref-10]; [@ref-14]). Using of the two molecular serotyping methods in combination allows the differentiation of all the 15 serovars. If all the picked colonies from one independent farm were determined to be the same serovar, then one of colonies was selected to be the representative. If more than one serovar were detected in a farm, then one representative for each different serovar was selected for further analysis. The designation of each clinical isolate includes information of province (ZJ for Zhejiang province), year (09 for year of 2009), sequence number (01 for the first isolates of the year) of isolation, and serovar (S1 for serovar 1 etc., Su for unknown serovar) of the isolate.

*IscR* sequencing and analysis
------------------------------

Primers for amplification of complete open reading frame of *iscR* gene were designed based on the *iscR* gene sequence of the strain SH0165 (GenBank accession number: [CP001321](CP001321)) ([@ref-35]), and listed in [Table 1](#table-1){ref-type="table"}. Amplicon of each isolate was purified and cloned into pMD 19 T vector, and send to TSINGKE Biological Technology Co., Ltd for gene sequencing. *IscR* gene for each isolate was sequenced twice in both the forward and reverse direction. *IscR* sequences of 15 reference strains (GenBank accession numbers: [KC795297](KC795297), [KC795318](KC795318), [KC795335](KC795335), [KC795364](KC795364), [KC795350](KC795350), [KC795383](KC795383), [KC795404](KC795404), [KC795422](KC795422), [KC795440](KC795440), [KC795459](KC795459), [KC795480](KC795480), [KC795495](KC795495), [KC795512](KC795512), [KC795532](KC795532), [KC795549](KC795549)) of *H. parasuis* were originated from a previous study ([@ref-12]). Alignment of the *iscR* sequence was prepared with MEGA 7.0, Lasergene 7 or DNAMAN 9. Phylogenetic tree was decorated with an online tool iTOL v4.2.3 (<https://itol.embl.de/>).
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###### Primers used for the PCR assays for potential virulence markers and *iscR*.

![](peerj-07-6950-g009)

  -----------------------------------------------------------------------------------------------------------------------
  Gene                                   Primer name   Primers(5′-3′)                   Amplicon size (bp)   References
  -------------------------------------- ------------- -------------------------------- -------------------- ------------
  HAPS_0254                              B14-F\        ACACCTTATGCTTCCGCTAT\            146                  [@ref-34]
                                         B14-R         ACGGTAACAGAACAAGAGCC                                  

  HAPS_0254                              D45-F\        CTTCCGCTATCGCATTAA\              131                  
                                         D45-R         AACAGAACAAGAGCCTAAA                                   

  nhaC                                   E30-F\        GTCCAGGAAGCATAATACA\             312                  
                                         E30-R         TACAAGGTGGCGAGATAA                                    

  fhuA                                   E35-F\        TCTAAGCGATGGGATTGAGC\            461                  
                                         E35-R         GGTGGCGTAAGACGTGATT                                   

  hhdA                                   MP_A1\        GGTTCTAGTTCACAAACAGCCAATAC\      964                  [@ref-27]
                                         MP_A2         GATATTTACCCCTGCCTTCATTGTATC                           

  hhdB                                   MP_B1\        ATCTTGCCCTGATTAGAGAGTAGGAGT\     557                  
                                         MP_B2         GTGAATATAGCCCTTATCCAAATAGGC                           

  hsdR                                   hsdR-F\       ATGACTATTGAAACAACGCCTATCA\       544                  [@ref-36]
                                         hsdR-R        GAACTTGGTTAAAGGCTTCC                                  

  hsdS[\*](#table-1fn1){ref-type="fn"}   hsdS-F\       ATGATAGAAAGTCGTTTTATTGAAAAG\     1,219                This study
                                         hsdS-R        GAAAACTTAATAATTTCTCTCTGTA                             

  ompP2                                  ompP2-F\      ATGAAAAAAACACTAGTAGCA\           1,092                
                                         ompP2-R       TTACCATAATACACGTAAACC                                 

  HPS_21058                              21058-F\      CCGAAAGCATAGATCCAAATGC\          590                  [@ref-13]
                                         21058-R       CCACCTTGTTTACTTGCTTCTGC                               

  HPS_21059                              21059-F\      CGTAGCATACGCACACCTAAAG\          720                  
                                         21059-R       GAAAGGGCAATAGATACATTTCGG                              

  vtaA                                   AV1-F\        AAATATTTAGAGTTATTTGGAGTC\        190\                 [@ref-8]
                                         V1-R\         AATATACCTAGTAATACTAGACTTAAAAG\   222                  
                                         NV1-R         CAGAATAAGCAAAATCAGC                                   

  iscR                                   iscR-F\       ATGAAATTAACTTCACGAGGACG\         447                  This study
                                         iscR-R        TTAATGGTGATGATCGTGGCAG                                
  -----------------------------------------------------------------------------------------------------------------------

**Note:**

Primers of the gene were newly designed in this study and were different from the original one.

Clinical backgrounds and detection of PVMs
------------------------------------------

Isolates from systemic sites such as spleen, brain, pericardium liquid, pleural effusion, seroperitoneum, and joint were considered to be systemic ones, and those from lungs and nasal cavities were considered to be respiratory ones and nasal ones, respectively. To further confirm the population structure and its relevance with clinical phenotype, 12 PVMs from five pieces of literatures were selected. Primers of one of the selected PVMs (*hsdS*) were newly designed in this study ([Table 1](#table-1){ref-type="table"}), and primers of other selected PVMs are the same with that in the literatures ([@ref-27]; [@ref-34]; [@ref-36]; [@ref-13]; [@ref-8]). The presence or absence of the selected PVMs in all the isolates were determined by PCR. Two or more strains from the same farm with any difference in respect of serovar, *iscR* clade, presence or absence of any PVMs were considered to be different isolates. The differences in average number of PVMs between serovars were determined by One-way ANOVA with SPSS Statistics 17.0. Differences were considered statistically significant when *P* \< 0.05.

Accession numbers
-----------------

The nucleotide sequences of *iscR* for the 148 isolates were submitted to GenBank. The accession numbers for the individual CDSs are [MH982282](MH982282)--[MH982429](MH982429).

Results
=======

Separation of clinical isolates into two deeply divergent groups by *iscR*-based phylogenetic analysis
------------------------------------------------------------------------------------------------------

Iron-sulfur cluster regulator gene was presented in all 148 isolates used in this study with the consistent open reading frame size of 447 bp. Phylogenetic sequence analysis of *iscR* amino acid sequences showed that the isolates were divided into two deeply divergent clades, which were designated as clade I and clade II ([Fig. 1](#fig-1){ref-type="fig"}). Dominant sequence type (ST1 and ST6) in each clade were further aligned with *iscR* of other Gram-negative bacteria, and simultaneous amino acid substitutions at highly conserved residue 29, 68, 77 made clade I *H. parasuis* an evolutionarily distant lineage from this and other Gram-negative species ([Fig. 2A](#fig-2){ref-type="fig"}). Amino acid sequence comparison revealed nine sequence types from the clinical isolates, and amino acid substitutions at residue 29, 68, 70--71, 77--78, 140 took place at 100% or nearly 100% between *iscR* of the two clades ([Fig. 2B](#fig-2){ref-type="fig"}). Four *iscR* protein sequence types were identified from the 15 reference strains, of which three were identical to those from the clinical isolates in this study ([Fig. S1](#supp-1){ref-type="supplementary-material"}).

![Phylogenetic tree of *iscR* proteins from 148 isolates.\
The proteins were highly conserved within both of the clade but deeply divergent between the two clades. Molecular Phylogeny was analyzed by Maximum Likelihood method using MEGA7 and decorated with an online tool iTOL v4.2.3 (<https://itol.embl.de/>).](peerj-07-6950-g001){#fig-1}

![Alignment of *iscR* protein sequences of *H. parasuis*.\
(A) Conservation of *iscR* proteins from Gram-negative bacteria. *IscR* protein of the dominant sequence type in each clade (ST1 for clade I and ST6 for clade II) was aligned. Residue numbering refers to the *H. parasuis* *iscR* sequence. DNA-binding domain, encompassing the HTH motif and a wing, was indicated with arrows. Fe/S cluster ligands were indicated with triangles. Strictly conserved amino acids were highlighted in dark blue, and decreasing residue conservation was represented by a color gradient from red to green. Alignment was prepared with DNAMAN 9. (B) Representatives of the nine sequence types were aligned using Lasergene (MegAlign). Amino acid residue of the sequence type 1 (ST1) were used as marker, and residues that match ST1 exactly were hide (as "."). The number of isolates represented by each sequence type is shown in the brackets. The clades distribution of each sequence type were indicated.](peerj-07-6950-g002){#fig-2}

Of all the isolates used in this study, clade I isolates were more prevalent (62.2%) than clade II isolates (37.8%). A higher proportion of isolates were systemic ones in clade I (44.6%) than that in clade II (30.4%) ([Fig. 3A](#fig-3){ref-type="fig"}). No tissue tropism was seen in respect of *iscR*-based phylogeny, as isolates from all the systemic sites can be found in both clades ([Fig. 3B](#fig-3){ref-type="fig"}). It is noteworthy that 93.8% of the isolates from pericardial effusion are belong to clade I ([Fig. 3B](#fig-3){ref-type="fig"}).

![Clade distribution (A) and isolation site (B) of systemic isolates.\
The number of isolates are indicated with data tags in the histogram. (A) Distribution of nasal, respiratory, and systemic isolates in clade I and clade II. (B) Isolation site of systemic isolates in clade I and clade II.](peerj-07-6950-g003){#fig-3}

Clear correlation between serovar and *iscR*-based phylogeny
------------------------------------------------------------

The two molecular serotyping methods allow the assignment of 144 (97.3%) isolates to 13 serovars except serovar 3 and 15, and 4 isolates (2.7%) could not be assigned to any of the 15 serovar known so far. Serovar 4 (18.9%) and serovar 12 (18.9%) were the most prevalent followed by serovar 13 (16.2%) and serovar 5 (13.5%) ([Fig. 4A](#fig-4){ref-type="fig"}). Isolates within most of the serovars tend to be distributed in the same clade. Serovars 4, 5, and 14 were dominated by clade I isolates, while serovars 1, 2 and 7 were dominated by clade II isolates ([Fig. 4A](#fig-4){ref-type="fig"}). Although slightly higher proportion of serovar 12 and 13 isolates were found in clade I, the distribution of isolates in the two serovars was relatively equal in both clades. For the remainder of the serovars, the number of isolates was too low to be able to restrict them to one clade.

![*IscR*-based phylogenic (A) and clinical relevance (B) of isolates in each serovar.\
(A) Clade distribution of isolates in each serovar. (B) Number of systemic, respiratory, and nasal isolates in each serovar.](peerj-07-6950-g004){#fig-4}

Systemic isolates were found in 10 of the 13 serovars identified. Of all the serovars with not less than five isolates, systemic isolates were more common in serovar 13 (54.2%) and serovar 12 (50%), and similar proportion of systemic isolates were found in serovar 1, 4, 5 ranging from 35% to 37.5%, which were followed by serovar 7 (20%) and serovar 14 (14.3%) ([Fig. 4B](#fig-4){ref-type="fig"}). These data indicate that virulence varies among serovars, and serovars 13 and 12 are more strongly linked to systemic infections.

Presentation of PVMs showed obvious correlation with *iscR*-based phylogeny and serovar
---------------------------------------------------------------------------------------

To further confirm the population structure and its relevance with clinical phenotype, distributions of 12 previously identified PVMs were investigated in all the 148 isolates. OmpP2 and *vtaA* genes could be detected in 100% and 98.6% of the isolates, respectively. Only four isolates were identified to be avirulent by the *vtaA* method, of which one was isolated from joint of diseased pig. Hence, presence of *ompP2* and *vtaA* gene showed low resolution of the isolates, and the other 10 PVMs were selected in the following studies.

The positive rates of most of the PVMs were similar among serovars (4, 5, 12, 13, and 14) which were dominated by isolates in clade I and among serovars (1, 2, and 7) which were dominated by isolates in clade II. The positive rates were clearly different when compared between serovars of one group (serovars 4, 5, 12, 13, and 14) and the other group (serovars 1, 2, and 7). Most of the PVMs (8/10) were more prevalent in clade I than in clade II ([Fig. 5](#fig-5){ref-type="fig"}). Of all the serovars with not less than 5 isolates, serovar 5 isolates carried the most PVMs with the average number of 7.35, while serovar 1 isolates carried the least with an average number of 1.5. Serovars dominated by clade I isolates were found with presence of remarkable higher average number of PVMs than those dominated by clade II isolates (*P* \< 0.05) ([Fig. 6](#fig-6){ref-type="fig"}). Interestingly, average number of PVMs in serovar 12 and 13 were similar to the serovars dominated by clade I isolates ([Fig. 6](#fig-6){ref-type="fig"}), although the distribution of isolates of the two serovars was relatively equal in both clades. In this study, only one isolate was found with the presence of all the 10 selected PVMs ([Fig. 7](#fig-7){ref-type="fig"}).

![Distribution of potential virulence markers in each serovar.\
Percent of isolates with the presence of potential virulence markers in each serovar.](peerj-07-6950-g005){#fig-5}

![Average number of potential virulence markers (PVMs) carried by the isolates in each serovars.\
Data were shown as mean + S.D. A *P*-value was computed using the one-way ANOVA with SPSS Statistics 17.0. Variations were considered statistically significant when the *P*-value was ≤0.05, which is indicated with "\*".](peerj-07-6950-g006){#fig-6}

![Maximum likelihood phylogenetic tree with the 148 isolates of *H. parasuis*, based on iscR protein sequence alignment.\
The tree was constructed with MEGA7, and decorated using ItoL (<https://itol.embl.de/>). Clade colors indicate the divergence of clade I (red) and clade II (blue). Inner circle represents lineage for each strains, and background color of the text label at each node indicates the serovar of the strain. The middle circle shows the isolation site of the strain. The outer circle shows the presence (red) or absence (green) of the 10 selected potential virulence markers (PVMs) in each isolates.](peerj-07-6950-g007){#fig-7}

Higher strain diversity in isolates from multi-strain infected farms
--------------------------------------------------------------------

A total of 34 PVMs profiles were identified based on the presence or absence of the 10 selected genes ([Table 2](#table-2){ref-type="table"}). The most prevalent profile was shared by 39 isolates, followed by 22 isolates in profile 20. More than half of the profiles (58.8%) were represented by only one isolate, which suggests high gene heterogeneity in accessory genome among isolates. Of the six profiles with no less than five isolates, systemic isolates were most prevalent in profile 27 (4/5) and least prevalent in profile 29 (0/10). Similar proportion of systemic isolates (29--46%) were observed in other profiles ([Table 2](#table-2){ref-type="table"}). Moreover, 10.2% of the systemic isolates do not carry any of the 10 selected PVMs ([Table 2](#table-2){ref-type="table"}), and all of which were distributed in clade II with the exception of one serovar unknown isolate ([Fig. 7](#fig-7){ref-type="fig"}). Neither presence of any of the selected PVMs nor the number of PVMs carried by the isolates showed correlation with clinical phenotype of systemic infection ([Fig. 7](#fig-7){ref-type="fig"}).

10.7717/peerj.6950/table-2

###### Potential virulence markers (PVMs) profiles and systemic isolates distribution in each profile.

![](peerj-07-6950-g010)

  No. of PVMs   Serial number of the profiles   No. of systemic/total isolates in the profile   HAPS_0254 (B14)   HAPS_0254 (D45)   nhaC   fhuA   hhdA   hhdB   hsdS   hsdR   HPS-21058   HPS-21059
  ------------- ------------------------------- ----------------------------------------------- ----------------- ----------------- ------ ------ ------ ------ ------ ------ ----------- -----------
  0             1                               6/13                                            −                 −                 −      −      −      −      −      −      −           −
  1             2                               2/7                                             −                 −                 −      −      −      −      −      −      \+          −
  3             1/1                             −                                               \+                −                 −      −      −      −      −      −      −           
  2             4                               0/1                                             −                 −                 −      −      −      −      −      \+     \+          −
  5             2/3                             −                                               −                 −                 −      −      −      −      −      \+     \+          
  6             0/1                             −                                               −                 −                 −      −      −      \+     \+     −      −           
  7             0/1                             −                                               −                 \+                −      \+     −      −      −      −      −           
  3             8                               0/1                                             −                 \+                −      −      \+     −      −      −      \+          −
  9             0/1                             −                                               −                 −                 −      −      −      −      \+     \+     \+          
  10            0/1                             \+                                              \+                −                 −      −      −      −      \+     −      −           
  11            0/1                             \+                                              \+                −                 −      \+     −      −      −      −      −           
  4             12                              0/1                                             −                 −                 \+     −      \+     \+     −      \+     −           −
  13            2/2                             \+                                              \+                \+                −      −      \+     −      −      −      −           
  14            1/1                             −                                               \+                −                 −      \+     −      −      \+     \+     −           
  5             15                              0/1                                             −                 \+                \+     −      \+     \+     −      −      \+          −
  16            1/1                             \+                                              \+                \+                −      \+     −      −      \+     −      −           
  17            1/1                             \+                                              \+                \+                −      \+     \+     −      −      −      −           
  18            2/2                             \+                                              \+                \+                −      −      \+     −      \+     −      −           
  19            1/3                             −                                               −                 \+                −      \+     \+     \+     \+     −      −           
  6             20                              9/22                                            \+                \+                \+     \+     \+     \+     −      −      −           −
  21            1/1                             −                                               −                 \+                \+     \+     \+     \+     \+     −      −           
  22            3/4                             \+                                              \+                \+                −      \+     \+     −      \+     −      −           
  23            1/1                             \+                                              \+                \+                \+     −      \+     −      \+     −      −           
  24            1/1                             −                                               \+                \+                −      \+     \+     −      −      \+     \+          
  25            0/1                             \+                                              \+                \+                −      \+     −      \+     \+     −      −           
  26            0/1                             \+                                              \+                −                 −      \+     \+     \+     \+     −      −           
  7             27                              4/5                                             \+                \+                \+     \+     \+     \+     −      \+     −           −
  28            13/39                           \+                                              \+                \+                −      \+     \+     \+     \+     −      −           
  29            0/10                            \+                                              \+                \+                \+     \+     \+     −      −      −      \+          
  8             30                              1/1                                             \+                \+                \+     \+     \+     \+     −      \+     \+          −
  31            5/13                            \+                                              \+                \+                \+     \+     \+     \+     \+     −      −           
  9             32                              1/3                                             \+                \+                \+     \+     \+     \+     \+     \+     \+          −
  33            0/2                             \+                                              \+                \+                \+     \+     \+     \+     \+     −      \+          
  10            34                              1/1                                             \+                \+                \+     \+     \+     \+     \+     \+     \+          \+
  Total         34                              59/148                                                                                                                                    

Of all the 125 independent pig farms, multi-strain (two or three) infection was found in 16% of the pig farms and single strain infection was found in the other 84% pig farms. An average of every 4.4 isolates from the single strain infection farm produce one PVMs profile, while every 2.2 isolates from the multi-strain infection farm produce one PVMs profile ([Table 3](#table-3){ref-type="table"}). Hence, multi-strain infection in one farm resulted in more diverse PVMs profiles in those isolates, which indicates that frequent gene transfer among isolates took place in multi-strain infected farms.

10.7717/peerj.6950/table-3

###### Potential virulence markers (PVMs) profiles in single and multi-strain infected farms.

![](peerj-07-6950-g011)

  Infection mode   No. of farms (%)   No. of isolates   No. of PVMs profiles
  ---------------- ------------------ ----------------- ----------------------
  Single strain    105 (84)           105               24
  Multi-strain     20 (16)            43                20

Potential gene exchange at the capsule locus
--------------------------------------------

To study the possible recombination between strains at the capsule locus, all isolates were clustered based on pattern similarity of PVMs. Two distinct clusters were identified, and were designated as cluster A and cluster B ([Fig. 8](#fig-8){ref-type="fig"}). Most of the isolates (92.1%) of serovar 4, 5, 12, 13, and 14 harbored more than five PVMs, and were distributed in cluster B. Most of the isolates (78.3%) of serovar 1, 2, and 7 only have less than two PVMs, and were listed in cluster A ([Fig. 8](#fig-8){ref-type="fig"}). Coincidently, clear separation of isolates from those serovars (4, 5, 12, 13, and 14) and other serovars (1, 2, and 7) was observed in *iscR*-based phylogeny analysis ([Fig. 4A](#fig-4){ref-type="fig"}). It indicates that these two clusters were possibly originated from two independently evolutionary lineages, which may have branched off from each other for a long evolutionary period.

![Hierarchical clustering of *H. parasuis* isolates based on the pattern similarity of potential virulence factors.\
Isolates were ordered along the columns based on the similarity in the presence (red) and absence (black) pattern of 10 potential virulence factors (HAPS_0254 (B14), HAPS_0254 (D45), *nhaC*, *fhuA*, *hhdA*, *hhdB*, *hsdS*, *hsdR*, HPS_21058, and HPS_21059). The similarity matrix was calculated using the Euclidean distance. Cluster analysis was performed by the Hierarchical clustering (HCL) through the cluster analysis procedure of MeV (Multiple Experiment Viewer) v4.9.0 package.](peerj-07-6950-g008){#fig-8}

Recombination event may take place when two or more strains co-exist in one farm, especially when in the same infected organ or commensal site. A small portion of isolates (21.7%) of serovar 1, 2, and 7 such as ZJ1510-S1 and ZJ1310-S7 were divided into cluster B. Similarly, a small portion of strains (7.9%) of serovar 4, 5, 12, 13, 14 were listed in cluster A, for instance, ZJ1604-S4, ZJ1207-S13, ZJ1405-S13, and ZJ1424-S13 etc., ([Fig.8](#fig-8){ref-type="fig"}). All these isolates harbored PVMs characteristic that do not match the majority of isolates of the same serovar, but consistent with PVMs characteristic of serovars which were mainly distributed in the other cluster. It indicates that these isolates may have undergone gene exchange between one serovar group (1, 2 or 7) and the other serovar group (4, 5, 12, 13, and 14) at or around the site of the capsule locus. Hence, isolates in the same serovar can vary greatly in terms of PVMs, which could lead to differences in the pathogenicity and immunogenicity within one serovar. It would be more difficult to identify in this study when exchange of capsule locus take place between serovars with similar PVMs characteristics.

Discussion
==========

Phylogeny and population structure of *H. parasuis* were widely studied, and *H. parasuis* strains could be divided into two groups in a variety of ways ([@ref-23]; [@ref-25]; [@ref-30]; [@ref-11]; [@ref-20]; [@ref-33]). Results of current study on correlation between population structure and virulence were contradictory. *H. parasuis* strains in some sub-groups tend to be virulent ([@ref-26]; [@ref-24]; [@ref-25]; [@ref-33]), while no association between population structure and clinical virulence was found in others ([@ref-38]; [@ref-4]; [@ref-11]). No strong correlation between clinical phenotype and *iscR*-based phylogeny or PVMs profiles was observed in this study.

The relationship between serotype and other typing methods has been evaluated ([@ref-30]; [@ref-17]; [@ref-39]), but correlation were only been identified in a few reports ([@ref-4]; [@ref-11]). In this study, isolates of serovar 4, 5, and 14 were found predominantly distributed in clade I, and those of serovar 12 and 13 were mostly found in clade I, while those of serovar 1, 2, and 7 were predominantly in clade II. It is similar to the results that separation of serovars (serovar 5, 12, 13 predominantly in clade I and serovar 7 in clade II) was found between the two clades in a previous study ([@ref-11]). Our study was also consistent with another report, in which serovar 5, 13, 14 were found only in cluster I and serovar 2 was only found in cluster II ([@ref-4]).

Systemic isolates were most frequently seen in serovar 13 in this study. In a previous study, serovar 13 were not the most prevalent one in respect of total isolation frequency, but was the most prevalent one with regard to the frequency of systemic isolates ([@ref-6]). Serovar 5 and 4 were determined to be more strongly linked to disease in another study ([@ref-11]). Mega data on correlation between serovar and virulence or clinical phenotype is still too limited to understand the relationship. Moreover, virulence of isolates varies greatly within the same serovar ([@ref-16]; [@ref-36]), and the reason for the variation is still to be determined. In this study, some isolates carry completely different PVMs compared to most of the counterparts within the same serovar, which indicates that those isolates may vary extensively in the accessory genome. The difference in the accessory genome may be responsible to the variation of virulence within one serovar. Genes in the accessory genome had been linked to differences in clinical phenotype ([@ref-11]). The vast genetic heterogeneity among isolates may pose a challenge to vaccine development ([@ref-31]).

In this study, selected PVMs were similarly distributed in serovars of which the isolates were predominantly distributed in the same clade, but huge differences were found when compared in between the clades. Hence, similarity of PVMs distribution in the accessory genome further suggest the close relationship among serovars dominated by isolates in the same clade. Moreover, phylogenetic analysis of gene content of the capsule loci support the close relationship among serovar 1, 2, and 7 ([@ref-12]), which is consistent with our finding that isolates of those serovars were all found in the same clade with exception of one isolate of sevovar 2. The coincidence of i*scR*-based phylogeny, separation of serovars and similarity of PVMs distribution in the accessory genome strongly suggests the independent evolution of the two branches of *H. parasuis*. The phylogenetic and amino acid substitution analysis of *iscR* inferred that clade II was the first to branch off from its ancestor, and clade I was possibly originated from clade II at the early stage of evolution. Long term of independent evolution may have resulted in a huge difference in the accessory genome. Pronounced difference between the accessory genome of the two clades had been observed in a previous study ([@ref-11]).

Serovar 12 and 13 were found in relatively equal proportions in both clades in this study, but were identified predominantly in one clade in other literature ([@ref-11]). Most of the serovar 12 or 13 isolates in clade II were found harboring typical PVMs characteristics of the counterparts in clade I, which indicates that those isolates were probably originated from clade I and transformed into clade II isolates through homologous recombination at or around the site of *iscR* gene. Since *iscR* was the target gene for population structure analysis in this study, isolates that came across gene exchange at this site of the chromosome may be shifted from one clade to another. It is noteworthy that gene exchange among isolates within the same clade would be difficult to spot due to the similar genetic background. Higher rates of homologous recombination for the clinical isolates compared with the non-clinical isolates have been observed in *H. parasuis* ([@ref-32]). More complex of PVMs profile were observed in isolates from multi-strain infected farm, indicating more frequent gene exchange in those isolates. Both higher prevalence and higher proportion of systemic isolates in serovar 12 and 13 increase the opportunity for them to contact with other isolates through co-infection, which may be part of the reason that leads to the higher rates of gene exchange in those serovars. Hence, extensive recombination within the species makes it harder to decipher the population structure of *H. parasuis*.

No isolate from healthy pigs was included for comparison in this study, and the absence of commensals was a possible reason for the low resolution of *vtaA* and *ompP2* in differentiation of the isolates although these two genes were also found in all strains including both commensals and systemic isolates in other studies ([@ref-21]; [@ref-11]). The common pathogens that co-infected with the *H. parasuis* isolates in our diagnostic center are porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, *Streptocccus suis*, *Bordetella bronchiseptica* etc. Recent research showed that many previously suggested virulence factors were not appropriate markers of virulence ([@ref-11]; [@ref-31]). In this study, a total of six systemic isolates harbored none of the PVMs, co-infection with other viral or bacterial pathogens were found for only three of the isolates. No correlation was found between the 10 selected PVMs and clinical virulence of the isolates. Those PVMs were probably serovar or clade specific genes emerged during evolution. To a certain extent, those PVMs may contribute to virulence, but they are not the genes that enable the organism to be virulent.

Of the 20 farms of multi-strain infection, systemic disease caused by multi-strains (ZJ10151-Su and ZJ10152-S2) was found in one farm, which stress the need for full assessment of the causative strains before treatment. Of the 86 lung isolates, a total of 24 isolates were isolated from lungs with presence of fibrinous inflammation, and the others were isolated from lungs with barely pneumonia. No difference was observed between the lung isolates from the two different clinical cases in respect of serovar distribution, PVMs profile and *iscR* phylogeny. Moreover, some of the pathogens such as *S. suis* and *Mycoplasma hyorhinis* could also cause lesions similar to Glässer's disease, and we could not exclude the co-infection of all of these possible agents especially for *M. hyorhinis* in this study. Hence, virulence factors involved in invasion are still to be determined for the agent.

Conclusions
===========

Iron-sulfur cluster regulator is a reliable marker for studying population structure of *H. parasuis*, while other factors should be included to avoid the interference of gene exchange. The two lineages of *H. parasuis* may have undergone independent evolution, but shows no difference in clinical virulence. Wide distribution of systemic isolates across the entire population poses new challenge for development of vaccine with better cross-protection. Our study provide new information for better deciphering the population structure of *H. parasuis*, which helps understanding the extreme diversity within this pathogenic bacterium.
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###### Alignment of iscR protein sequences of 15 reference strains of *H. parasuis* using Lasergene (MegAlign).

*IscR* sequences of 15 reference strains originated from a previous study (28). Sequence name includes information on both name (e.g., Nagasaki) and serovar (e.g., "S5R" is short for serovar 5 reference strain) of the strain. IscR sequence of Nagasaki-S5R were used as markers, and residues that match Nagasaki-S5R exactly were hidden (as " . "). The clade distribution of each sequence type was indicated on the left.

###### 

Click here for additional data file.
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###### Information of isolates used in this study.

Names, serovar, potential virulence markers, isolation sites of isolates are shown in this table.

###### 

Click here for additional data file.
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